...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Message: BETonMACE Enrollment

and patient discontinuation rate which we didn't hear anything about until the last year. In my estimation the funding issue added about 6 months to the projected time to 250 events.

Tada, i don't remember reading about the discontinuing rate, ... can you remind me what we heard,..?

So the 6 months late (trial ended april 2019 instead of nov 2018) was because of funding and not because treated group was doing well...?


New Message
Please login to post a reply